Atlas Trials

Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes

Clinical trial NCT07516847 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07516847
Sponsor
Seug yun Yoon, MD
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndromes (MDS)Anemia
Start date
2026-09-01
Primary completion
2029-01-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.